StageZero Life Sciences (StageZero Life Sciences) Market Cap : $3.59 Mil (As of Apr. 30, 2024)

View and export this data going back to . Start your Free Trial

What is StageZero Life Sciences Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). StageZero Life Sciences's share price for the quarter that ended in Sep. 2023 was $0.0404. StageZero Life Sciences's Shares Outstanding (EOP) for the quarter that ended in Sep. 2023 was 122.72 Mil. Therefore, StageZero Life Sciences's market cap for the quarter that ended in Sep. 2023 was $4.96 Mil.

StageZero Life Sciences's quarterly market cap declined from Mar. 2023 ($6.99 Mil) to Jun. 2023 ($5.66 Mil) and declined from Jun. 2023 ($5.66 Mil) to Sep. 2023 ($4.96 Mil).

StageZero Life Sciences's annual market cap declined from Dec. 2020 ($35.51 Mil) to Dec. 2021 ($20.90 Mil) and declined from Dec. 2021 ($20.90 Mil) to Dec. 2022 ($4.67 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. StageZero Life Sciences's Enterprise Value for Today is $4.93 Mil.

StageZero Life Sciences Market Cap Historical Data

The historical data trend for StageZero Life Sciences's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

StageZero Life Sciences Market Cap Chart

StageZero Life Sciences Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Market Cap

Get a 7-Day Free Trial

5.76

7.82

35.51

20.90

4.67

StageZero Life Sciences Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Market Cap	Get a 7-Day Free Trial															5.80	4.67	6.99	5.66	4.96

Competitive Comparison of StageZero Life Sciences's Market Cap

For the Diagnostics & Research subindustry, StageZero Life Sciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

StageZero Life Sciences's Market Cap Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, StageZero Life Sciences's Market Cap distribution charts can be found below:

* The bar in red indicates where StageZero Life Sciences's Market Cap falls into.

StageZero Life Sciences Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

StageZero Life Sciences's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	$0.0443	*	105.465
	=	$4.67

StageZero Life Sciences's Market Cap for the quarter that ended in Sep. 2023 is calculated as

Market Cap (Q: Sep. 2023 )	=	Share Price (Q: Sep. 2023 )	*	Shares Outstanding (EOP) (Q: Sep. 2023 )
	=	$0.0404	*	122.717
	=	$4.96

StageZero Life Sciences (OTCPK:SZLSF) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

StageZero Life Sciences Market Cap Related Terms

Thank you for viewing the detailed overview of StageZero Life Sciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

StageZero Life Sciences (StageZero Life Sciences) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » StageZero Life Sciences Ltd (OTCPK:SZLSF) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

61N1:Germany SZLS:Canada

Address

70 East Beaver Creek Road, Unit 30, Richmond Hill, ON, CAN, L4B 3B2

Website

https://www.stagezerolifesciences.com

StageZero Life Sciences Ltd is a vertically integrated healthcare company at the nexus of three sectors of healthcare; Early Cancer Detection, Liquid Biopsy, and Global Telehealth. It is focused on minimizing the risk of cancer and other chronic diseases through early detection and intervention. It continues to develop and commercialize proprietary molecular diagnostic tests for the early detection of diseases and personalized health management, with a focus on cancer-related indications. It has developed a proprietary platform technology, the Sentinel Principle, to identify novel biomarkers from whole blood. The Company's lead product, Aristotle, is a blood-based molecular diagnostic assessment that can detect an individual's current risk for potentially having a variety of cancers.